To further verify the effects of G3BP1 and YWHAZ on chemoresistance, we constructed a chemotherapeutic drug-resistant GC cell line by culturing MGC80-3 cells with continuous exposure to capecitabine or oxaliplatin for 3 months (Supplementary Fig. 9a). This evidence concerns the gene G3BP1 and gastric cancer.